Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Washington Group International was a leading global engineering, construction, and management services firm that maintained a specialized division dedicated to the life sciences and pharmaceutical industries. The company provided comprehensive engineering, procurement, and construction (EPC) services, focusing on the design and build of complex manufacturing facilities, laboratories, and cleanroom environments. Through its acquisition of Raytheon Engineers & Constructors, it became a primary partner for major biopharmaceutical companies requiring validated production systems and high-tech infrastructure. The firm played a critical role in scaling up manufacturing capabilities for various therapeutic modalities, including small molecules and biologics. In 2007, the company was acquired by URS Corporation, which was subsequently acquired by AECOM in 2014.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Washington Group International.